Matthew Levy

Matthew-LEVY

Vitrisa Therapeutics

2016-2017

Affiliations

Albert Einstein College of Medicine

Technologies

Digital Health Technology

Indication

Autoimmune & Inflammation

Basic Research

Oncology

Platform technology for rapid development of highly stable, high affinity clinic ready ligands called aptamers.

Newsletter Signup

Corporate Supporters

Community Service Providers